The publications on this site are part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726

Informa
Skip to Page Content

Full Deal Summary

Teva Pharmaceutical Industries Ltd. and Amarin Corp. PLC have settled patent litigation surrounding Teva's ANDA for generic Vascepa (icosapent ethyl) capsules. Under the settlement, Teva can market icosapent ethyl in the US beginning on August 9, 2029. Vascepa is a single molecule product consisting of the omega-3 acid known as EPA in ethyl-ester form and is proven to lower triglyceride levels without raising LDL-cholesterol levels. Ongoing patent litigation continues with West-Ward Pharmaceuticals Corp and Dr. Reddy's Laboratories Inc.


+ Show All | – Hide All

Financials

There are no financials available.

Deal Information


Click a keyword for comparable deals.

Deal Industry Pharmaceuticals
Generic Drugs
Deal Status Final
Deal Type Alliance
Marketing-Licensing
Latest Phase at Time of Deal Marketing
Marketed

Product Information


Click a keyword for comparable deals.

Product 1 of 1
Product Type Pharmaceutical
Generic Name Icosapent ethyl
Brand Name Vascepa
Lab Code AMR01
Mechanism of Action Caspase inhibitor
Omega-3 fatty acid stimulant
Highest Phase at Time of Deal Marketing
Marketed
Product Therapeutic Area(s) of Focus Cardiovascular
Arteriosclerosis-Atherosclerosis
Blood cholesterol
Licenser Name Amarin Corp. PLC
Licensee Name Teva Pharmaceutical Industries Ltd.

Company Information


Click a keyword for comparable companies.

Amarin Corp. PLC www.amarincorp.com | Ticker: AMRN
View Company Profile | View Company Deals
Company Location Worldwide
Europe
Western Europe
Ireland
Industry Biotechnology
Pharmaceuticals
Ownership Public
Therapeutic Area(s) of Focus Cardiovascular
Alias(es) Ethical Holdings

Teva Pharmaceutical Industries Ltd. www.tevapharm.com | Ticker: TEVA
View Company Profile | View Company Deals
Company Location Worldwide
Middle East
Israel
Industry Pharmaceuticals
Generic Drugs
OTC, Consumer
Ownership Public
Therapeutic Area(s) of Focus Non-Specific